CXXC5 drove inflammation and ovarian cancer proliferation via transcriptional activation of ZNF143 and EGR1
Cellular Signalling · 2024
DOI: 10.1016/j.cellsig.2024.111180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2024. Verfasst von Ting Geng und 25 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, College of Pharmacy, Jiangsu Ocean University, Lianyungang 222005, China. Hauptthemen laut MEDLINE: Cell Proliferation, DNA-Binding Proteins, Gene Expression Regulation, Neoplastic, Inflammation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
CXXC5, a zinc-finger protein, is known for its role in epigenetic regulation via binding to unmethylated CpG islands in gene promoters. As a transcription factor and epigenetic regulator, CXXC5 modulates various signaling processes and acts as a key coordinator. Altered expression or activity of CXXC5 has been linked to various pathological conditions, including tumorigenesis. Despite its known role in cancer, CXXC5's function and mechanism in ovarian cancer are unclear. We analyzed multiple public databases and found that CXXC5 is highly expressed in ovarian cancer, with high expression correlating with poor patient prognosis. We show that CXXC5 expression is regulated by oxygen concentration and is a direct target of HIF1A. CXXC5 is critical for maintaining the proliferative potential of ovarian cancer cells, with knockdown decreasing and overexpression increasing cell proliferation. Loss of CXXC5 led to inactivation of multiple inflammatory signaling pathways, while overexpression activated these pathways. Through in vitro and in vivo experiments, we confirmed ZNF143 and EGR1 as downstream transcription factors of CXXC5, mediating its proliferative potential in ovarian cancer. Our findings suggest that the CXXC5-ZNF143/EGR1 axis forms a network driving ovarian cell proliferation and tumorigenesis, and highlight CXXC5 as a potential therapeutic target for ovarian cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, College of Pharmacy, Jiangsu Ocean University, Lianyungang 222005, China.
- Department of Hepatobiliary and Pancreatic Surgery, Hainan General Hospital, Affiliated Hainan Hospital of Hainan Medical College, Haikou 570311, China.
- Department of Obstetrics and Gynecology, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, Hubei, China.
- Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, College of Pharmacy, Jiangsu Ocean University, Lianyungang 222005, China. Electronic address: msjgdpu@126.com.
- Cancer Center and Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA. Electronic address: weiliu@mcw.edu.
- Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Electronic address: liushunfang28@163.com.
Zitieren
APA
Geng, T., Sun, Q., He, J., Chen, Y., Cheng, W., Shen, J., Liu, B., Zhang, M., Wang, S., Asan, K., Song, M., Gao, Q., Song, Y., Liu, R., Liu, X., Ding, Y., Jing, A., Ye, X., Ren, H., …, & Ji, J. (2024). CXXC5 drove inflammation and ovarian cancer proliferation via transcriptional activation of ZNF143 and EGR1. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2024.111180
Vancouver
Geng T, Sun Q, He J, Chen Y, Cheng W, Shen J, et al. CXXC5 drove inflammation and ovarian cancer proliferation via transcriptional activation of ZNF143 and EGR1. Cellular Signalling. 2024. doi:10.1016/j.cellsig.2024.111180
BibTeX
@article{Geng2024,
author = {Geng, Ting and Sun, Qigang and He, Jingliang and Chen, Yulu and Cheng, Wenhao and Shen, Jing and Liu, Bin and Zhang, Meiqi and Wang, Sen and Asan, Kadirya and Song, Mengwei and Gao, Qi and Song, Yizhuo and Liu, Ruotong and Liu, Xing and Ding, Yuanyuan and Jing, Aixin and Ye, Xiaoqing and Ren, Hongyu and Zeng, Kaile and Zhou, Ying and Zhang, Boyu and Ma, Shaojie and Liu, Wei and Liu, Shunfang and Ji, Jing},
title = {CXXC5 drove inflammation and ovarian cancer proliferation via transcriptional activation of ZNF143 and EGR1},
journal = {Cellular Signalling},
year = {2024},
doi = {10.1016/j.cellsig.2024.111180}
}
EUVIMED